Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France restricts intravascular radiation therapy

This article was originally published in Clinica

Executive Summary

The French healthcare products safety agency, AFSSAPS, has published on its website a report on the risks and benefits of intravascular radiation therapy products used to prevent restenosis in coronary stents. This is the only FDA-approved treatment for in-stent restenosis and the report was considered a priority because the technique is new (some two years old) and potentially risky.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel